GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Other Gross PPE

NKGen Biotech (NKGen Biotech) Other Gross PPE : $4.54 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Other Gross PPE?

NKGen Biotech's Other Gross PPE for the quarter that ended in Mar. 2024 was $4.54 Mil.

NKGen Biotech's quarterly Other Gross PPE declined from Sep. 2023 ($4.14 Mil) to Dec. 2023 ($4.06 Mil) but then increased from Dec. 2023 ($4.06 Mil) to Mar. 2024 ($4.54 Mil).

NKGen Biotech's annual Other Gross PPE declined from Dec. 2021 ($4.76 Mil) to Dec. 2022 ($4.42 Mil) and declined from Dec. 2022 ($4.42 Mil) to Dec. 2023 ($4.06 Mil).


NKGen Biotech Other Gross PPE Historical Data

The historical data trend for NKGen Biotech's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Other Gross PPE Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Other Gross PPE
4.76 4.42 4.06

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial 4.42 - 4.14 4.06 4.54

NKGen Biotech Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


NKGen Biotech (NKGen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.